QUESTION: My husband used to have severe rosacea, and it really affected him socially. He was very self-conscious about his ...

Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...

Massachusetts Gov. Maura Healey signed a new law Wednesday promoting greater transparency on prescription drug pricing as a step toward tackling the high cost of health care and medications. The law ...

Dandruff shampoos like Selsun Blue (selenium sulfide) may reduce skin inflammation, which also makes the skin less inviting for mites. Others may find that your husband’s regimen is also helpful for ...

"Between diabetes, you've got asthma, heart conditions. How do you price lifesaving medications out of someone's affordability?" Moore asked. The new law will cap prescription drug copays at $25.

A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found those insured through Medicare Advantage received less expensive cancer ...

Jan. 2, 2025 — One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health of cancer patients when accompanied by psychotherapy, a new study suggests.

(Nasdaq: FBIO) ("Fortress") announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and Priority review Sentynl's New Drug ... lesions of rosacea in adults Cosibelimab ...

About 53 million Americans were enrolled in a Medicare prescription drug plan in 2024. Enrollees who take the priciest drugs will get some relief this year with a $2,000 cap on drug costs.

After hours: January 13 at 6:22:25 PM EST Loading Chart for DRUG ...

Shop the best skin care products for rosacea from popular brands like Aveeno, EltaMD, Cetaphil, La Roche-Posay, CeraVe and ...

and administration of the medication and urgent situations when a delay would harm the patient (e.g., the new onset of nausea or pain or a sudden change in the patient's clinical status).